Intrinsic Value of S&P & Nasdaq Contact Us
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Back to all stocks

Boston Scientific Corporation BSX NYSE

NYSE • Healthcare • Medical - Devices • US • USD

SharesGrow Score
80/100
5/7 Pass
SharesGrow Intrinsic Value
$103.80
+62.6%
Analyst Price Target
$108.35
+69.8%
Metric TTM (2025-03 – 2025-12)
Revenue $20.08B
Gross Profit $14.11B
Gross Margin 70.3%
Operating Income $4B
Net Income $2.89B
Net Margin 14.4%
EPS (Diluted) $1.93

People Also View

AMGN
AMGN
Amgen Inc.
$350.95
+0.32%
 ABT
ABT
Abbott Laboratories
$101.07
+0.38%
 GILD
GILD
Gilead Sciences, Inc.
$140.45
+1.02%
 PFE
PFE
Pfizer Inc.
$27.13
-0.77%
 DHR
DHR
Danaher Corporation
$198.61
+1.40%
 SYK
SYK
Stryker Corporation
$345.88
-0.39%
 SNY
SNY
Sanofi
$47.64
+1.45%
 MDT
MDT
Medtronic plc
$88.12
+0.14%
Contact Us
🎓
SharesGrow Academy
Learn how to calculate Intrinsic Value and find undervalued stocks.
Weekly live sessions
📧 [email protected]
📞 +65 8912 8000
Send us a message